Advik Laboratories logo

Advik Laboratories financials and balance sheet

BSE: 531686Pharmaceuticals & BiotechnologySmall Cap

Last close ₹2.08₹0.00 (0.00%)

Share price at the BSE close on 19 Oct 2026. Previous close ₹2.08.

52-week range of traded prices to 19 Oct 2026
₹1.57Low, 2 Mar 2026₹2.08High, 15 Sep 2026
Market cap
₹3.98 Cr5,167th largest listed
P/E
Lossover the last 12 months
P/B
58.0
Dividend yield
Nonein the last 12 months
ROE
−180.6%
ROCE
−14.5%
Debt to equity
109.84
Volume, BSE
300

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Advik Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹4.09 Cr, year to Mar 2018A loss in 10 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs−0.5
  3. Other expenses−0.4
  4. Operating profit−0.9
  5. Depreciation−0.1
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax−1.1
  10. Tax0.0
  11. Net profit−1.0

What the company owns

  • Plant, investments and other assets₹8 Cr
  • Inventory₹0 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹8 Cr
  • Other liabilities₹1 Cr
  • Owed to suppliers₹0 Cr
  • Net worth₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March.Advik Laboratories quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 13 JunMar 2020Filed 1 AugMar 2021Filed 6 JulMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 2 JulMar 2025Filed 27 JunMar 2026Filed 28 May
Revenue from operations2.274.090.820.000.000.030.000.000.000.00
9.714.621.550.684.130.710.950.800.760.95
Materials and goods bought8.243.530.830.000.000.050.050.000.000.00
Employee costs0.780.650.490.450.400.420.490.530.520.53
Other expenses0.690.440.240.233.730.240.420.270.240.41
Operating profit before depreciation−7.44−0.53−0.72−0.68−4.13−0.68−0.95−0.80−0.76−0.95
Operating margin−327.8%−12.9%−87.7%––−2,086.4%––––
Materials, % of revenue363.0%86.2%100.1%––158.0%––––
Employee costs, % of revenue34.3%15.9%58.9%––1,300.3%––––
Other expenses, % of revenue30.5%10.8%28.7%––728.1%––––
Depreciation and amortisation0.590.590.590.570.560.510.150.150.150.15
Operating profit after depreciation−8.03−1.11−1.31−1.25−4.69−1.19−1.09−0.95−0.91−1.09
Other income0.600.060.020.020.200.260.020.090.050.04
Finance costs0.000.000.000.000.000.000.000.000.000.00
One-off items––0.000.000.000.000.000.000.000.00
Profit before tax−7.43−1.06−1.29−1.24−4.49−0.93−1.07−0.85−0.86−1.06
−0.06−0.19−0.05−0.07−0.08−0.79−0.02−0.020.03−0.04
Net profit−7.37−0.87−1.25−1.17−4.42−0.14−1.05−0.83−0.90−1.02
Other comprehensive income––0.010.000.000.020.020.010.010.01
Total comprehensive income––−1.23−1.16−4.41−0.12−1.04−0.82−0.89−1.01
Net margin−324.9%−21.2%−151.1%––−437.0%––––
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations10.712.018.822.119.933.929.712.21.4
10.611.919.221.818.6–27.511.41.8
Materials and goods bought8.610.317.920.917.729.826.29.80.4
Employee costs––0.30.30.4–0.60.80.8
Other expenses––0.90.60.5–0.60.90.7
Operating profit before depreciation0.10.1−0.40.31.3–2.20.8−0.4
Operating margin1.0%0.9%−1.9%1.4%6.4%–7.4%6.6%−30.3%
Materials, % of revenue––95.1%94.6%89.2%–88.3%80.0%31.6%
Employee costs, % of revenue––1.8%1.3%1.9%–2.2%6.4%57.6%
Other expenses, % of revenue––5.0%2.7%2.5%–2.2%7.1%48.2%
Depreciation and amortisation0.40.40.40.50.5–0.70.60.6
Operating profit after depreciation−0.3−0.2−0.8−0.20.7–1.50.2−1.0
Other income0.10.00.80.30.20.30.60.00.0
Finance costs0.20.30.30.80.91.31.21.10.1
Profit before tax−0.4−0.5−0.3−0.70.01.01.0−0.9−1.2
Tax0.0––––0.50.5−0.20.0
Net profit−0.4−0.5−0.3−0.70.00.50.5−0.7−1.2
Net margin−3.3%−4.2%−1.5%−3.1%0.1%1.5%1.6%−5.5%−87.8%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 13 JunMar 2020Filed 1 AugMar 2021Filed 6 JulMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 2 JulMar 2025Filed 27 JunMar 2026Filed 28 May
9.58.44.03.82.82.01.10.1
Share capital19.119.119.119.119.119.119.119.1
Reserves−9.6−10.7−15.2−15.3−16.3−17.1−18.0−19.0
Borrowings2.52.51.95.86.87.37.57.5
7.27.36.76.17.27.78.18.2
0.80.70.70.30.20.20.20.2
Total assets17.616.411.310.210.29.99.38.5
12.211.29.18.18.17.87.36.6
5.35.22.22.02.12.12.01.9
Net debt2.52.51.95.86.87.37.57.5
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 6 JulMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 2 JulMar 2025Filed 27 JunMar 2026Filed 28 May
−0.93−4.34−0.87−0.63−0.57−0.59
3.01−3.950.040.060.170.31
Receivables1.940.560.010.010.010.01
Inventories0.000.020.050.000.000.15
Payables−0.050.030.080.000.00−0.01
Other working capital1.12−4.56−0.090.050.160.16
Capital spending0.000.010.120.020.000.00
Free cash flow−0.93−4.35−0.98−0.65−0.57−0.59
1.540.46−0.100.120.380.52
−0.613.880.960.510.180.07
Dividends paid0.000.000.000.000.000.00
Shares bought back0.000.000.000.000.000.00
Shares issued0.000.000.000.000.000.00
Net change in cash0.000.00−0.010.000.000.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 13 JunMar 2020Filed 1 AugMar 2021Filed 6 JulMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 2 JulMar 2025Filed 27 JunMar 2026Filed 28 May
Earnings per share−₹3.86−₹0.45−₹0.65−₹0.61−₹2.31−₹0.07−₹0.55−₹0.43−₹0.47−₹0.53
Diluted earnings per share−₹3.86−₹0.45−₹0.65−₹0.61−₹2.31−₹0.07−₹0.55−₹0.43−₹0.47−₹0.53
Book value per share––₹4.99₹4.38₹2.07₹2.00₹1.46₹1.03₹0.57₹0.04
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)15.38.03.60.71.42.74.06.16.13.2

Ratios

Standalone, years to March.Advik Laboratories PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 13 JunMar 2020Filed 1 AugMar 2021Filed 6 JulMar 2022Filed 3 JunMar 2023Filed 29 MayMar 2024Filed 2 JulMar 2025Filed 27 JunMar 2026Filed 28 May
Revenue growth67.5%80.4%−79.9%−100.0%––−100.0%–––
Return on equity––−13.1%––−3.6%––––
Return on capital employed––−10.9%−11.5%−79.8%−12.3%−11.4%−10.2%−10.7%−14.4%
Debt to equity––0.260.300.491.522.423.696.90109.84
Receivable days––1,157––390––––
Inventory days––2532,60,19986,3683,9114,085–––
Payable days––7267,20614,2358701,614–––
Cash conversion cycle, days––1,338––3,430––––
Working capital days––257––19,543––––
Asset turnover––0.050.000.000.000.000.000.000.00
Assets per rupee of net worth––1.841.902.252.763.074.236.3215.50
Sales per rupee of plant––0.140.000.000.010.000.000.000.00
Capital spending to depreciation––––0.000.020.800.120.000.00
Plant being built, % of plant in use––92.2%95.5%83.3%82.0%82.1%81.2%75.9%65.9%
Interest cover is left blank for the years to Mar 2017, Mar 2018, Mar 2019, Mar 2020, Mar 2021, Mar 2022, Mar 2023, Mar 2024, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−11.5%
Measure5 years3 years
Return on capital employed, average−11.8%−11.8%
Asset turnover, average0.000.00
Debt to equity, average24.8840.15

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−7.00−1.79−0.59
Cash from investing1.401.030.52
Cash from financing5.590.760.07
Capital spending0.150.020.00
Dividends paid0.000.000.00
Shares bought back0.000.000.00
Shares issued for cash0.000.000.00
Borrowings raised5.600.760.07
Borrowings repaid0.000.000.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Altman Z-scorePublished threshold 1.81−0.82–−3.55−2.63−2.86−2.92−3.34−4.23
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––−36.2634.81−0.86−3.19−7.39−10.71
Receivables growth less revenue growthOur threshold 0 percentage points–96.94––74.86–––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–99.76−200.42−2,036.733.91100.00––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−4.32––––
Assets under construction, years of additionsOur threshold 2 years of additions–––302.7028.99192.92––
A threshold marked as ours has no published figure; it is the line we read the check against.